CLOV (Clover Health Investments, Corp) Stock Analysis - News
Clover Health Investments, Corp (CLOV) is a publicly traded Healthcare sector company. As of May 21, 2026, CLOV trades at $3.59 with a market cap of $1.79B and a P/E ratio of 0.00. CLOV moved +2.57% today. Year to date, CLOV is +38.61%; over the trailing twelve months it is -2.71%. Its 52-week range spans $1.58 to $4.87. Analyst consensus is buy with an average price target of $2.98. Rallies surfaces CLOV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in CLOV news today?
Clover Health Posts $27M Q1 Profit, 62% Revenue Growth, 51% Membership Increase: Clover Health posted first-quarter GAAP net income of $27 million on $749 million in revenue, rising 62%, with adjusted EBITDA of $40 million and Medicare Advantage membership up 51% to 155,773. For 2026, it projects 154,000–158,000 members (+46%), revenue of $2.81–$2.92 billion (+49%) and net income of $0–$20 million.
Clover Health Posts $27M Q1 Profit, 62% Revenue Growth, 51% Membership Increase: Clover Health posted first-quarter GAAP net income of $27 million on $749 million in revenue, rising 62%, with adjusted EBITDA of $40 million and Medicare Advantage membership up 51% to 155,773. For 2026, it projects 154,000–158,000 members (+46%), revenue of $2.81–$2.92 billion (+49%) and net income of $0–$20 million.
Does Rallies summarize CLOV news?
Yes. Rallies summarizes CLOV news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is CLOV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLOV. It does not provide personalized investment advice.
